TY - JOUR
T1 - Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement
T2 - JACC Scientific Expert Panel
AU - Rodés-Cabau, J.
AU - Ellenbogen, Kenneth A.
AU - Krahn, Andrew D.
AU - Latib, A.
AU - Mack, Michael
AU - Mittal, Suneet
AU - Muntané-Carol, Guillem
AU - Nazif, Tamim M.
AU - Sondergaard, Lars
AU - Urena, Marina
AU - Windecker, Stephan
AU - Philippon, François
N1 - Funding Information:
Dr. Rodés-Cabau has received institutional research grants from Edwards Lifesciences, Boston Scientific, and Medtronic, and holds the Research Chair “Fondation Famille Jacques Larivière” for the Development of Structural Heart Disease Interventions. Dr. Ellenbogen is a consultant for Medtronic, Boston Scientific, and Abbott; has received lecture honoraria from Medtronic, Boston Scientific, Biotronik, and Abbott; and has received research grants from Medtronic and Boston Scientific. Dr. Krahn is a consultant for Medtronic; and has received research grants from Boston Scientific and Medtronic. Dr. Latib has served on the Advisory Board for Medtronic; and has received honoraria from Abbott Vascular. Dr. Mittal is consultant for Boston Scientific and Medtronic. Dr Nazif is a consultant for and has received institutional grants from Edwards LifeSciences, Medtronic, Boston Scientific, and BioTrace Medical. Dr. Philippon is a consultant for Medtronic. Dr. Muntané-Carol is supported by a research grant from the Fundación Alfonso Martín Escudero (Madrid, Spain). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Rishi Puri, MBBS, PhD, served as Guest Associate Editor for this paper.
Funding Information:
The authors thank Melanie Coté, MSc, and Claire Gibrat, PhD, from the Quebec Heart and Lung Institute, Quebec City, Canada, for their help in the preparation of Figures and Tables. Dr. Rodés-Cabau has received institutional research grants from Edwards Lifesciences, Boston Scientific, and Medtronic, and holds the Research Chair “Fondation Famille Jacques Larivière” for the Development of Structural Heart Disease Interventions. Dr. Ellenbogen is a consultant for Medtronic, Boston Scientific, and Abbott; has received lecture honoraria from Medtronic, Boston Scientific, Biotronik, and Abbott; and has received research grants from Medtronic and Boston Scientific. Dr. Krahn is a consultant for Medtronic; and has received research grants from Boston Scientific and Medtronic. Dr. Latib has served on the Advisory Board for Medtronic; and has received honoraria from Abbott Vascular. Dr. Mittal is consultant for Boston Scientific and Medtronic. Dr Nazif is a consultant for and has received institutional grants from Edwards LifeSciences, Medtronic, Boston Scientific, and BioTrace Medical. Dr. Philippon is a consultant for Medtronic. Dr. Muntané-Carol is supported by a research grant from the Fundación Alfonso Martín Escudero (Madrid, Spain). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Rishi Puri, MBBS, PhD, served as Guest Associate Editor for this paper.
Publisher Copyright:
© 2019 American College of Cardiology Foundation
PY - 2019/8/27
Y1 - 2019/8/27
N2 - Despite major improvements in transcatheter aortic valve replacement (TAVR) periprocedural complications in recent years, the occurrence of conduction disturbances has not decreased over time and remains the most frequent complication of the procedure. Additionally, there has been an important lack of consensus on the management of these complications, which has indeed translated into a high degree of uncertainty regarding the most appropriate treatment of a large proportion of such patients along with major differences between centers and studies in pacemaker rates post-TAVR. There is therefore an urgent need for a uniform strategy regarding the management of conduction disturbances after TAVR. The present expert consensus scientific panel document has been formulated by a multidisciplinary group of interventional cardiologists, electrophysiologists, and cardiac surgeons as an initial attempt to provide a guide for the management of conduction disturbances after TAVR based on the best available data and group expertise.
AB - Despite major improvements in transcatheter aortic valve replacement (TAVR) periprocedural complications in recent years, the occurrence of conduction disturbances has not decreased over time and remains the most frequent complication of the procedure. Additionally, there has been an important lack of consensus on the management of these complications, which has indeed translated into a high degree of uncertainty regarding the most appropriate treatment of a large proportion of such patients along with major differences between centers and studies in pacemaker rates post-TAVR. There is therefore an urgent need for a uniform strategy regarding the management of conduction disturbances after TAVR. The present expert consensus scientific panel document has been formulated by a multidisciplinary group of interventional cardiologists, electrophysiologists, and cardiac surgeons as an initial attempt to provide a guide for the management of conduction disturbances after TAVR based on the best available data and group expertise.
KW - aortic stenosis
KW - conduction disturbances
KW - pacemaker
KW - transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=85070533586&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070533586&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2019.07.014
DO - 10.1016/j.jacc.2019.07.014
M3 - Review article
C2 - 31439219
AN - SCOPUS:85070533586
SN - 0735-1097
VL - 74
SP - 1086
EP - 1106
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 8
ER -